Should You Sell Smith & Nephew plc & Buy Petrofac Limited Today?

Petrofac Limited (LON: PFC) and Smith & Nephew plc (LON: SN) are under the spotlight today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Smith & Nephew (LSE: SN) is not in bargain territory, but its valuation is moving in the right direction.

Its stock has only risen 6% since mid-2014 and has gone nowhere so far in 2015 — a disappointing trend I’d expect to last until the end of the year, unless more bad news contributes to a meaningful drop in its value.

In fairness, I would feel more comfortable investing in Petrofac (LSE: PFC), an oilfield services group with a market cap of £3.1bn, which could turn out to be a less cyclical play than many expect it to be.  

Smith & Nephew overpriced

Smith & Nephew announced yesterday the voluntary removal from the market of “46mm diameter and smaller femoral heads and corresponding acetabular cup components for the BIRMINGHAM HIP Resurfacing (BHR) System,” which did little to lift spirits in a declining market. 

Make no mistake: Smith & Nephew  is a solid business, with strong fundamentals, but based on its forward valuation for earnings and core cash flows, its shares look overpriced by at least 20%. I am inclined to suggest that S&N could be a good buy at about 900p a share, but it currently trades at a much higher 1,141p.

Its projected dividend is well covered, but at around 1.9%-2.2% in the next couple of years, there are better alternatives in the marketplace, and if pressure builds on operating margins, its dividend policy may come under scrutiny. Smith & Nephew currently trades in line with market consensus estimates, which have risen by 40% since the end of 2013 — the market has been betting on a takeover or a break-up of the company for some time, and even more so in the last 18 months. 

I am happy to sit and wait. 

Petrofac upside

Petrofac is an opportunity that’s almost too good to be true — one that offers a forward yield comfortably double that of Smith & Nephew. 

The dividend is covered — just — by core earnings, recent results showed, but Petrofac announced today the extension and amendment of a revolving credit facility (an undrawn credit, it’s like a credit card!), which gives it more financial flexibility. Of course, this is great news, as its cost of funding would fall in the event that the facility was drawn.

Banking fees are also on their way down, which testifies to a company that boasts a strong pool of relationship banks. 

Moreover, its lowly forward multiples based on earnings and cash flows do not seem to take into account likely expanding margins over the next couple of years, given that Petrofac is committed to efficiency. Its stock price has risen 30% this year. Is that a lot?

I do not think so. Its shares currently trade in line with consensus estimates, but I would not be surprised if analysts became more bullish over time. My personal price target is 1,167p, for an implied upside of 28% into the first quarter of 2016. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »